Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Shares, No Par Value
-
Shares outstanding
-
28.5M
-
Number of holders
-
1
-
Total 13F shares, excl. options
-
47.1K
-
Shares change
-
-12.3K
-
Total reported value, excl. options
-
$112K
-
Value change
-
-$29.2K
-
Number of sells
-
-1
-
Price
-
$2.38
Significant Holders of Oncocyte Corporation - Common Shares, No Par Value (OCX) as of Q4 2024
1 filing reported holding OCX - Oncocyte Corporation - Common Shares, No Par Value as of Q4 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.